Inhibiting lipid absorption using basic biopolymers

Future Lipidology

Volumn 2, Issue 5, 2007, Pages 547-555

  Tsujita, Takahiro ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basic polysaccharide; Inhibitor; Lipolysis; Obesity; Pancreatic lipase; Polylysine

Indexed keywords

3 TRIETHYLAMINO 2 HYDROXYPROPYL; AMINOBENZOYL; ANTIOBESITY AGENT; BETA LACTOGLOBULIN; BIOPOLYMER; BOVINE SERUM ALBUMIN; CHITOSAN; DIETHYLAMINOETHYL; ENZYME INHIBITOR; EPSILON POLYLYSINE; HISTONE; PIPERIDINOETHYL; PROTAMINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE INHIBITOR; UNCLASSIFIED DRUG;

CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME INHIBITOR COMPLEX; ENZYME SPECIFICITY; FAT INTAKE; HUMAN; INTESTINE ABSORPTION; LIPID ABSORPTION; LIPOLYSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW;

EID: 35548960030     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460875.2.5.547     Document Type: Review

References (27)

1. Astrup A: The role of dietary fat in obesity. Semin. Vasc. Med 5(1), 40-47 (2005).
2. Phan CT, Tso P: Intestinal lipid absorption and transport. Front. Biosci. 6, D299-D319 (2001).
3. Rietsch J, Pattus F, Desnuelle P, Verger R: Further studies of mode of action of lipolytic enzymes. J. Biol. Chem. 252(12), 4313-4318 (1977).
4. Borgström B, Erlanson CB: Pancreatic lipase and co-lipase. Interactions and effects of bile salts and other detergents. Eur. J. Biochem. 37(1), 60-68 (1973).
5. Gargouri Y, Julien R, Bois AG, Verger R, Sarda L: Studies on the detergent inhibition of pancreatic lipase activity. J. Lipid Res. 24(10), 1336-1342 (1983).
6. Gargouri Y, Julien R, Sugihara A, Verger R, Sarda L: Inhibition of pancreatic and microbial lipases by proteins. Biochim. Biophys. Acta 795(2), 326-331 (1984).
7. Tsujita T, Sumiyoshi M, Takaku T, Momsen WE, Lowe ME, Brockman HL: Inhibition of lipases by ε-polylysine. J. Lipid Res. 44(12), 2278-2286 (2003).
8. Tsujita T, Takaichi H, Takaku T, Sawai T, Yoshida N, Hiraki J: Inhibition of lipase activities by basic polysaccharide. J. Lipid Res. 48(2), 358-365 (2007).
9. Brockman HL: General features of lipolysis: reaction scheme, interfacial structure and experimental approaches. In: Lipases. Borgström B, Brockman HL (Eds). Elsevier, Amsterdam, The Netherlands, 3-46 (1984).
10. Aloulou A, Rodriguez JA, Fernandez S, van Oosterhout D, Puccinelli D, Carrière F: Exploring the specific features of interfacial enzymology based on lipase studies. Biochim. Biophys. Acta 1761(9), 995-1013 (2006).
11. Moreau H, Moulin A, Gargouri Y, Noël JP, Verger R: Inactivation of gastric and pancreatic lipases by diethyl p-nitrophenyl phosphate. Biochemistry 30(4), 1037-1041 (1991).
12. Ransac S, Gargouri Y, Marguet F et al.: Covalent inactivation of lipase. Meth. Enzmol. 286, 190-231 (1997).
13. Borgström B: Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin Biochim. Biophys. Acta 962(3), 308-316 (1988).
14. Cudrey C, van Tilbeurgh H, Gargouri Y. Verger R: Inactivation of pancreatic lipases by amphiphitic reagents 5-(dodecyldithio-2-nitrobenzoic acid and tetrahydrolipstatin. Dependence upon partitioning between micellar and oil phases. Biochemistry 32(50), 13800-13808 (1993).
15. Hadvàry P, Sidler W, Meister W, Vetter W, Wolfer H: The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. J. Biol. Chem. 266(4), 2021-2027 (1991).
16. Lüthi-Peng Q, Märki HP, Hadváry P: Identification of the active-site serine in human pancreatic lipase by chemical modification of with tetrahydrolipstatin. FEBS Lett. 299(1), 111-115 (1992).
17. Han LK, Kimura Y, Kawashima T et al.: Anti-obesity effects of dietary tea saponin, a lipase inhibitor. Int. J. Obes. Relat. Metab. Disord. 25(4), 1459-1464 (2001).
18. Juhel C, Armand M, Pafumi Y et al.: Green tea extract (AR25) inhibits lipolysis of triglyceridcs in gastric and duodenal medium in vitro. J. Nutr. Biochem. 11(1), 45-51 (2000).
19. Ikeda I, Tsuda K, Suzuki Y et al.: Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. J. Nutr. 135(2), 155-159 (2005).
20. Chahinian H, Bezzine S, Ferraro F et al.: The β 5 loop of the pancreatic lipase C2-like domain plays a critical role in the lipase-lipid interactions. Biochemistry 41(46), 13725-13735 (2002).
21. Kahar P, Kobayashi K, Iwata T, Hiraki J, Kojima M, Okabe M: Production of ε-polylysine in an airlift bioreactor (ABR). J. Biosci. Bioeng. 93(3), 274-280 (2002).
22. Tsujita T, Matsuura Y, Okuda H: Studies on the inhibition of pancreatic and carboxylester lipases by protamine. J. Lipid Res. 37(7), 1481-1487 (1996).
23. Han LK, Kimura Y, Okuda H: Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 23(2), 174-179 (1999).
24. Tsujita T, Takaichi H, Takaku T, Aoyama S, Hiraki J: Antiobesity action of ε-polylysine, a potent inhibitor of pancreatic lipase. J. Lipid Res. 47(8) 1852-1858 (2006).
25. Hismiogullari AA, Bozdayi AM, Rahman K: Biliary lipid secretion. Turk. J. Gastroenterol. 18(2), 65-70 (2007).
26. Sumiyoshi M, Kimura Y: Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J. Pharm. Pharmacol. 58(2), 201-207 (2006).
27. Hiraki J, Ichikawa T, Ninomiya et al.: Use of ADME studies to confirm the safety of ε-polylysine as a preservative in food. Regul. Toxicol. Pharmacol. 37(2), 328-340 (2003).